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4Department of Pathology and Infectious Diseases, Faculty of Health and Medical Sciences, School of Veterinary Medicine, University of Surrey,
Guildford, Surrey, UK
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Abstract: Tuberculosis (TB) in wild boar (Sus scrofa) may be affected by coinfections with other pathogens, such
as porcine circovirus type 2 (PCV2). Therefore, sanitarymeasures focused on controlling PCV2 could be useful in
reducing the impact of TB in this wild suid. The aimof this studywas to explore whether vaccination against PCV2
targeting young animals affects TB prevalence and TB severity in wild boar. The study was conducted on a game
estate in mid-western Spain. Seventy animals of ages ranging from 4 to 8 months were captured, individually
identified, vaccinated against PCV2 and released, forming a vaccinated group. Not-captured animals cohabiting
with the vaccinatedwild boar constituted the control group. Animals fromboth groupswere hunted between 2013
and 2016 and a TB diagnosis based on pathological assessment and microbiological culture was made in all of
them. The effect of PCV2 vaccination on TB prevalence and severity was explored using generalized lineal models.
Whereas TB prevalence was similar in vaccinated and control groups (54.55 vs. 57.78%), vaccinated animals
showed less probabilities to develop generalized TB lesions. Furthermore, mean TB severity score was significantly
lower in vaccinated animals (1.55 vs. 2.42) suggesting a positive effect of PCV2 vaccination.
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INTRODUCTION AND PURPOSE
Bovine tuberculosis (TB) is a chronic bacterial disease
mainly caused by Mycobacterium bovis that leads to sig-
nificant economic losses worldwide (Hermoso de Mendoza
et al. 2006; Harris et al. 2014). Furthermore, M. bovis poses
a serious threat to public health as a zoonotic pathogen
(Müller et al. 2013) and may have an impact on the
preservation of endangered species, such as the Iberian lynx
(Lynx pardina) (Gortázar et al. 2008).Published online: March 9, 2018
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In recent decades, bovine TB has been eradicated from
many European nations (e.g. France, Germany) (EFSA
2014). However, in other countries, such as Spain, bovine
TB prevalence remains stable, despite great efforts made
through official eradication campaigns (RASVE 2015). A
high prevalence of bovine TB found in mid-western areas
of Spain has been related to the presence of wild reservoirs
of M. bovis, mainly wild boar (Sus scrofa) (Gortázar et al.
2005). Thus, measures focused on controlling TB in this
wild reservoir will be necessary to eradicate bovine TB in
cattle from these areas (Garcı́a-Bocanegra et al. 2012).
TB prevalence and severity in wild boar have been
related to the existence of other concomitant pathogens
that frequently infect these animals. Thus, TB prevalence
has been positively associated with a high prevalence of
porcine circovirus type 2 (PCV2) (Risco et al. 2013a).
Furthermore, TB-affected wild boar that are also coinfected
with pathogens, such as PCV2 or Metastrongylus spp., have
shown higher probabilities of suffering from severe TB le-
sions (Risco et al. 2014). In this scenario, sanitary measures
focused on controlling these concomitant pathogens, like
vaccination against PCV2 or periodic anthelmintic treat-
ments, could be useful to reduce TB prevalence and TB
severity in the wild boar.
The aim of this study was to explore whether a single-
dose vaccination against PCV2 targeting young animals
affects TB prevalence and TB severity in wild boar.
METHODS
Study Area
The study was conducted on a game estate with a well-
known history of TB (prevalence of 52% in December of
2012) and located in Oropesa (Toledo, central Spain,
4000041.200N, 509014.300W). This area has a continental
thermal Mediterranean climate, with hot dry summers (26–
28C) and mild and moderately wet winters (7–10C). The
vegetation consists mainly of scrublands of Cistus spp. and
arbutus (Arbutus unedo) and evergreen oak forests (Quercus
suber). The estate, which covers 2000 Ha, is completely
surrounded by a fence to prevent the dispersion of the
approximately 350 wild boar that live there, and to avoid
the entrance of new animals. Wild boar are continuously
fed with a specific fodder (Jabalı́ Familia, Mercoguadiana
S.A., Spain) that is supplied in six feeders located
throughout the estate. All of these feeders are surrounded
by a fence with gates of different sizes allowing the selection
of the size of the animals that will be fed. In addition, these
gates are provided with a locking system allowing the en-
trance of animals but not their exit when it is activated,
acting as a selective feeding trap.
Experimental Design
The aim of the experimental design was to generate two
groups of animals (a control group and a PCV2 vaccinated
group), which were living in the same estate and under the
same conditions. To do this, three different capturing
events were conducted in the study area in August of 2013,
2014 and 2015. The selective feeding traps were used to
carry out the captures allowing the entrance of wild boar
ranging approximately from 4 to 8 months of age. Captures
were scheduled in August since this is the month when the
natural feed offered by the estate is scarcest, ensuring that
most of the wild boar population attended the fodders
(Ballesteros et al. 2009).
Captured animals were individually identified using a
microchip (Pet link, Datamars SA, Switzerland) applied
subcutaneously just behind the right ear and were vacci-
nated against PCV2 with one dose of a commercial vaccine
(Suvaxyn PCV2, Zoetis, Spain). The animals were then
immediately released and allowed to return to the rest of
the population. In addition, from a proportion of captured
wild boar (animals showing a null or low stress level during
the manipulation), blood samples were taken by punctur-
ing the ophthalmic sinus in order to assess the presence of
antibodies against PCV2 at the moment of the vaccination.
Captured animals (electronically identified and vacci-
nated) formed the vaccinated group in this experiment,
whereas animals of similar age, which were not captured
but were also living on the estate, formed the control
group. Animals belonging to both groups lived together in
the same TB epidemiological scenario until they were
hunted.
Sampling Procedure
Animals included in this study were sampled during
hunting events in December of 2013, 2014 and 2015. To
analyse only wild boar that could have been vaccinated
(vaccinated and control groups), sampled animals were
chosen according to their ages and taking into account the
year of the experiment. Thus, animals between 8 months
and 1 year of age were sampled in 2013; animals ranging
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between 8 months and 2 years in 2014; and finally, animals
between 8 months and 3 years in 2015. The age of the
hunted wild boar was assessed according to teeth replace-
ment patterns, following previously described protocols
(Boitani and Mattei 1992).
Once the animals included in the study were selected,
they were examined and sampled, and the presence of a
microchip behind the right ear was checked using an
appropriate reader. Animals with transponders were in-
cluded in the vaccinated group, whereas animals without
transponders formed the control group. Blood samples
were collected from studied animals by puncturing the
retro-orbital cavernous sinus (Arenas-Montes et al. 2013).
TB Diagnosis
TB diagnosis was based on the presence of TB-like lesions
and the microbiological isolation of M. bovis, following
previously described procedures (Risco et al. 2016). Briefly,
a post-mortem examination to detect visible TB-like lesions
was performed targeting the thoracic and abdominal or-
gans, and the main lymph nodes: submandibular,
retropharyngeal, mediastinal and mesenteric. The lungs
and cervical lymph nodes (submandibular and/or
retropharyngeal) were extracted from all the studied ani-
mals and stored at 4C for further procedures in the lab-
oratory.
The presence of M. bovis in sampled tissues was eval-
uated by microbiological isolation following standard cul-
ture procedures (Corner and Trajstman 1988), confirmed
by PCR and typed by spoligotyping (Cousins et al. 1991;
Kamerbeek et al. 1997). Positive wild boar were classified as
animals with a ‘localized TB pattern’ if M. bovis was con-
firmed in only one organ or lymph node, whereas those in
which M. bovis was confirmed in more than one organ or
lymph node were classified as ‘generalized TB pattern’
cases. Furthermore, a pathological score based on the ex-
tent of TB lesions and ranging between 0 (no lesions) and 5
(extensive lesions) was used to assess the severity of TB in
the studied wild boar (Menin et al. 2013).
PCV2 ELISA and PCV2 DNA Detection
In order to assess whether PCV2 vaccination produced a
serological response in vaccinated animals, antibody titre
against PCV2 was estimated in blood samples collected
from capture animals (pre-vaccination) and from hunted
wild boar (post-vaccination) using a commercial indirect
ELISA (INGEZIM CIRCO IgG, INGENASA S.A., Spain)
following manufacturer’s recommendations.
Furthermore, to evaluate the effect of PCV2 vaccina-
tion on PCV2 prevalence and viral load, a PCV2 diagnosis
was carried out in some of the studied animals. DNA from
their cervical lymph nodes was extracted using a com-
mercial kit (QiAmp DNA Mini Kit, Qiagen Ltd., UK)
following the manufacturer’s protocol. A specific real-time
PCR assay was then conducted using a previously described
pair of primers and a fluorescent probe (Brunborg et al.
2004). Duplicate reactions were run for template samples
(500 ng of DNA extracted from cervical lymph nodes),
standards and non-template controls. The number of DNA
copies present in each sample was estimated based on the
standard curve calculated using the thermocycler-specific
software (Applied Biosystem 7300, Thermo Fisher Scientific
Inc., USA). Results were expressed as numbers of PCV2
genome copies per 500 ng of DNA. Finally, to discount the
presence of PCR inhibitors in nasal samples included in this
study, a TaqMan base real-time PCR to detect the b-actin
gene was carried out using previously described primers,
probes and conditions (Toussaint et al. 2007).
Due to immunological protection acquired through
the PCV2 commercial vaccine being valid for 5 months,
and the age of vaccinated animals ranging between 4 and
8 months at the moment of vaccination, PCV2 ELISA and
PCV2 DNA detection used to confirm the efficacy of vac-
cination were only conducted on animals younger than
13 months at the time of sampling.
Statistical Analysis
Effect of PCV2 Vaccination on M. bovis Infection and TB
Severity
To explore the effect of PCV2 vaccination on TB devel-
opment in wild boar, we fitted two sets of independent
generalized linear models (GLM) with binomial errors and
logit link function, in which M. bovis infection (infected,
non-infected) and TB severity (localized or generalized
pattern) were explained by the single and the additive ef-
fects of vaccination against PCV2, age (in years) and their
two way interaction. The effect of age was included as an
explanatory covariate in these models because 1) it has been
reported to have an effect on both TB prevalence and TB
severity in wild boar (Vicente et al. 2006; Risco et al.
2013b); and 2) PCV2 vaccination produces a temporary
immunological protection (5 months) and hence, the effect
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of this treatment on TB development could be mild on
older animals. Another set of GLMs with similar explana-
tory variables but using a Gaussian error distribution, were
fitted to explain TB pathological score (1–5).
Among all the proposed models, the most parsimo-
nious one was selected to explain each response variable
following an information-theoretic approach based on the
Akaike Information Criterion corrected for small sample
sizes (AICc) (Burnham and Anderson 2003). The Akaike
weight (wi), that is, the relative likelihood of the model
given the data available, was also estimated. This statistical
procedure was performed using the package ‘stats’, version
3.0.2 of the statistical software R (Team 2017).
Effect of PCV2 Vaccination on Viral Load and Antibody
Titres
T test for paired samples was conducted to compare pre-
vaccination and post-vaccination mean PCV2 antibody ti-
tre in the vaccinated group. Furthermore, ordinary T test
was carried out to compare mean PCV2 antibody titre
between vaccinated and control animals at the time of
sampling.
The frequency of animals infected by PCV2 and the
viral load were compared between vaccinated and non-
vaccinated animals using Chi-square test and the Man
Whitney U test, respectively.
RESULTS
Captures and Hunting Events
A total of 70 animals between four and eight months of age
were captured, identified, vaccinated and released, in the
three captures carried out during this experiment (August
of 2013, 2014 and 2015, see Table 1). Thirty-three of these
captured animals were hunted-harvested during December
of 2014 and 2015, forming the vaccinated group. Further-
more, another 36 animals of similar ages but without
transponders were also hunted and included in the control
group (see Table 1). No differences in mean age (1.41 years
in both groups) or sex ratio were observed between control
and vaccinated groups.
TB Diagnosis and Relationship with PCV2 Vacci-
nation
M. bovis was isolated in 37 out of the 69 animals studied
(53.62%). Among TB positive animals, 21 (56.75%)
showed localized infection, whereas 16 showed generalized
patterns (43.25%). The number of M. bovis infected ani-
mals, the percentage of TB generalized patterns and the
mean TB pathological score found in each group (vacci-
nated and control) are summarized in Table 2.
According to our model selection procedure (see
Table 3), the most parsimonious model to explain M. bovis
Table 1. Number of Animals Captured, Identified and Vaccinated During the Three Captures Carried Out in August of 2013, 2014 and
2015; and Number of Animals Hunted in Hunting Events Celebrated in December of 2013, 2014 and 2015 Which Were Included in this
Study.
2013 2014 2015
Captured animals (August) 33 (10 #/23 $) 18 (10 #/8 $) 19 (10 #/9 $)
Hunted animals (December) Age < 1 year Age < 2 years Age < 3 years
Vaccinated – 15 (7 #/8 $) 18 (7 #/11 $)
Control – 10 (4 #/6 $) 26 (7 #/19 $)
Table 2. Results of TB Diagnosis, TB Severity Assessment and PCV2 Detection in the Animals Studied.
M. bovis infection TB lesion pattern Score PCV detection Mean PCV copies
Negative Positive Localized Generalized Positive Negative
Control group 17 (47.2%) 19 (52.7%) 7 (36.8%) 12 (63.2%) 2.42 12 (66.6%) 6 (33.4%) 1573.51 (SD = 6499.72)
Vaccinated group 15 (45.5%) 18 (54.5%) 14 (77.7%) 4 (22.3%) 1.55 8 (53.3%) 7 (46.7%) 85.71 (SD = 215.92)
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infection in studied wild boar did not include PCV2 vac-
cination as explanatory variable. Model including age as the
only explanatory variable was the most suitable option to
explain TB infections (wAge = 0.56, Deviance ex-
plained = 5.26%), showing a positive association between
age and the probabilities of TB infection.
Conversely, models including PCV2 vaccination as the
unique explanatory variable were the most parsimonious
options to explain TB severity [wPCV2 Vaccination = 0.56,
Deviance explained = 12.91%, odds ratio = 6 (1.49–
28.46)] and TB pathological score (wPCV2 Vaccination = 0.56,
Deviance explained = 11.17%, b = 0.44), showing that the
presence of generalized TB pattern and TB pathological
score were lesser in vaccinated animals (Fig. 1).
PCV2 ELISAs and PCV2 DNA Detection
PCV2 antibody titres found in vaccinated animals were
higher at post-vaccination time-point (mean = 1527) than
at pre-vaccination time-point (mean = 142.80, t = 6.8654,
P = 1.73e-5). Furthermore, vaccinated animals showed
higher mean PCV2 antibody titre (1195.50) than the con-
trol group (mean = 664.78, t = -2.62, P = 0.01) at the
time of sampling.
PCV2 DNA was detected in 58.49% (n = 20) of the
animals checked (n = 33) with a mean viral load of 1428
copies of PCV2 genome/500 ng DNA. Among the vacci-
nated group, the percentage of positive animals was 53.3%
(8/15) with a mean load of 31 copies of PCV2 genome/
500 ng DNA, whereas in the control group, the percentage
of positive animals was 66.6% (12/18) with a mean viral
load of 2514 copies of PCV2 genome/500 ng (see Table 2).
No statistically significant differences were found in the
frequency of animals infected by PCV2 (v2 = 0.178, P va-
lue = 0.67), nor in the PCV2 load (W = 151, P va-
lue = 0.33) between vaccinated and control animals.
DISCUSSION
The results generated by this experiment showed an asso-
ciation between single-dose PCV2 vaccination and TB
severity in wild boar. Animals vaccinated against PCV2
displayed less severe TB lesions than control animals, with a
Table 3. Model Selection to Explore the Influence of PCV2 Vaccination on the Probabilities of M. bovis Infection and TB Severity of
Studied Wild Boar.
Biological models K AICc Di wi
Response variable: M. bovis infection
Age 3 94.64 0.00 0.56
PCV vaccination + age 4 96.87 2.23 0.18
Mo 2 97.47 2.83 0.14
PCV vaccination 9 age 5 97.71 3.07 0.12
PCV vaccination 3 99.64 5.00 0.04611
Response variable: TB pattern
PCV vaccination 3 48.80 0.00 0.56
PCV vaccination + age 4 51.17 2.37 0.17
PCV vaccination 9 age 5 51.18 2.38 0.17
Mo 2 52.97 4.16 0.06999
Age 3 54.97 6.16 0.02578
Response variable: TB pathological score
PCV vaccination 3 126.45 0.00 0.56
PCV vaccination + age 4 127.75 1.30 0.29
Mo 2 128.45 2.01 0.21
PCV vaccination 9 age 5 129.73 3.28 0.10896
Age 3 130.16 3.71 0.08768
Generalized linear models with binomial (M. bovis infection and TB pattern) and Gaussian (TB pathological score) error structure have been used.
K number of parameters, including intercept, AICc Akaike Information Criterion corrected for small sample sizes, DAICc difference of AICc with respect to
the best model, wi Akaike weight, Mo null model only with the constant term.
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60% reduction in the number of animals suffering from TB
generalized patterns (63.2% in control group vs. 22.3% in
vaccinated group). In addition, mean TB pathological score
observed in vaccinated animals was 36% lower than mean
score found in control group (1.55 vs. 2.42). These findings
suggest that PCV2 vaccination targeting young animals
may help reduce TB severity in wild boar populations.
PCV2 infections in TB-affected wild boar may trigger
TB development, leading to more severe generalized TB
patterns (Risco et al. 2013a; Risco et al. 2014). Temporary
immunological protection (5 months) conferred by a sin-
gle-dose PCV2 vaccination in young wild boar seems to
limit the negative effects of this virus on TB development
under field conditions. Although some of the wild boar
(older than 13 months) were sampled when the immuno-
logical protection conferred by vaccination had finished,
the association between PCV2 vaccination and TB severity
did not depend on the age of the animals. In fact, models
trying to explain TB severity (TB patterns and TB patho-
logical score) in which age was included as explanatory
variable were discarded following AICc criteria.
The significant increment of PCV2 antibody titres
between pre-vaccination and post-vaccination time-points
confirms a serological response produced by PCV2 vacci-
nation. Furthermore, despite that the prevalence of PCV2
infections was similar in control and vaccinated animals,
the latest showed higher antibody titres which may be also
attributed to the effect of vaccination. Although not sig-
nificant (perhaps due to the low number of animals and a
large standard deviation, see Table 2), large differences
Fig. 1. TB prevalence, percentage of generalized TB patterns and TB pathological score, found in wild boar vaccinated against PCV2 and
control group; and PCV2 antibody titres found in vaccinated animals at pre-vaccination and post-vaccination time-points.
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were also observed in mean viral load found in lymph
nodes from the control (2514 copies/500 ng) and vacci-
nated groups (31 copies/500 ng), suggesting a positive ef-
fect of vaccination. In fact, animals with viral loads close to
those considered to be pathological in PCV2 infections (107
copies/500 ng of DNA) (Brunborg et al. 2004) were only
observed in animals from control group. These results are
in agreement with the aim of the vaccine used in this study
(Suvaxyn PCV, Zoetis, Spain) that is to reduce viral load
and limit clinical signs, but not protect against new PCV2
infections (Zoetis 2009).
In contrast to TB severity, TB prevalence was not
associated with PCV2 vaccination. A similar percentage of
M. bovis infected animals was found in both control
(54.5%) and vaccinated groups (52.7%). These results are
in agreement with those obtained in a previous experiment
which tried to modulate TB in buffalo using anthelmintic
treatments (Ezenwa and Jolles 2015). In that case, treat-
ment against parasites did not reduce TB prevalence in
treated animals, but raised the likelihood of survival of TB-
affected animals, suggesting a decrease in the severity of the
disease.
Improvement of survival rates in TB-affected buffalos
by anthelmintic treatment was related to a negative effect
at the population level, increasing the likelihood of the
spread microbial pathogens, including M. bovis (Ezenwa
and Jolles 2015). However, in the case of the wild boar, the
situation may be the opposite. PCV2 vaccination does not
directly reduce the probabilities of M. bovis infection in
wild boar but could reduce TB severity, which has been
positively associated with TB prevalence (Risco et al.
2013a) and M. bovis shedding in the wild boar (Santos
et al. 2015). Therefore, it would be expected that the
reduction of generalized TB patterns through PCV2 vac-
cination could lead to a decrease in TB prevalence. More
years of vaccination and greater vaccination pressure will
likely be necessary to note a significant reduction in TB
prevalence.
In conclusion, the results obtained in this work show
that PCV2 vaccination using feeding traps could be a
useful tool to reduce TB severity on wild boar game
estates. Further research will be necessary to assess
whether long-term PCV2 vaccination schedules are able
to reduce TB prevalence and to evaluate the combination
of this measure with other sanitary actions applicable to
this types of estates, such as vitamin D supplementation
(Risco et al. 2016) or TB vaccination (Dı́ez-Delgado et al.
2016).
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in Doñana Biosphere Reserve: The role of wild ungulates as
disease reservoirs in the last Iberian lynx strongholds. PLoS ONE
3:e2776
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